TipRanks
Go Ultimate55% OFF

Comparison Results

Comparison results
NamePricePrice ChangePrice TargetSmart ScoreExpense RatioAsset Under ManagementFollow
PBPHPortfolio Building Block World Pharma and Biotech Index ETF$30.76$31.66(2.92% Upside)0.13%1.15B
CANCTema Oncology ETF$42.35$60.13(41.97% Upside)0.75%217.39M
LFSCF/M Emerald Life Sciences Innovation ETF$44.87$67.06(49.46% Upside)0.54%123.99M
IBBQInvesco Nasdaq Biotechnology ETF$36.17$45.23(25.04% Upside)0.19%119.41M
HRTSTema Cardiovascular and Metabolic ETF$38.54$45.03(16.85% Upside)0.75%55.86M
OZEMRoundhill GLP-1 & Weight Loss ETF$30.35$46.94(54.67% Upside)0.59%54.39M
IBRNiShares Neuroscience and Healthcare ETF$33.29$54.53(63.82% Upside)0.47%6.60M
THNRAmplify Weight Loss Drug & Treatment ETF$25.36$34.60(36.47% Upside)0.59%5.68M
BIBProShares Ultra Nasdaq Biotechnology$120.53―0.95%99.12M
BISProShares UltraShort Nasdaq Biotechnology$10.46―0.95%1.82M

Performance Comparison

-50%0%50%Nov '25Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
PBPHPortfolio Building Block World Pharma and Biotech Index ETF30.765.7122.78%
CANCTema Oncology ETF42.3511.6337.86%
LFSCF/M Emerald Life Sciences Innovation ETF44.8712.6839.41%
IBBQInvesco Nasdaq Biotechnology ETF36.1710.0738.58%
HRTSTema Cardiovascular and Metabolic ETF38.546.4720.18%
OZEMRoundhill GLP-1 & Weight Loss ETF30.352.549.14%
IBRNiShares Neuroscience and Healthcare ETF33.293.5111.77%
THNRAmplify Weight Loss Drug & Treatment ETF25.362.7712.27%
BIBProShares Ultra Nasdaq Biotechnology120.5350.8673.01%
BISProShares UltraShort Nasdaq Biotechnology10.46-10.89-51.00%

ETFs Similar to PSIL FAQ

What is the cheapest alternative to PSIL?
Among the ETFs similar to PSIL, PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) has the lowest expense ratio, at 0.13% a year, compared with 1.00% for PSIL.
PSIL vs. PBPH: what is the difference?
PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) is the first ETF in PSIL's similar-ETF list. It has $1.15B in assets under management and a 0.13% expense ratio, against $46.28M and 1.00% for PSIL. Compare their performance, price targets and Smart Scores in the table above.